Cargando…

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target

Apolipoprotein (apo) B, the critical structural protein of the atherogenic lipoproteins, has two major isoforms: apoB48 and apoB100. ApoB48 is found in chylomicrons and chylomicron remnants with one apoB48 molecule per chylomicron particle. Similarly, a single apoB100 molecule is contained per parti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behbodikhah, Jennifer, Ahmed, Saba, Elyasi, Ailin, Kasselman, Lora J., De Leon, Joshua, Glass, Amy D., Reiss, Allison B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540246/ https://www.ncbi.nlm.nih.gov/pubmed/34677405 http://dx.doi.org/10.3390/metabo11100690

Ejemplares similares

Hydroxychloroquine Effects on THP-1 Macrophage Cholesterol Handling: Cell Culture Studies Corresponding to the TARGET Cardiovascular Trial
por: Ahmed, Saba, et al.
Publicado: (2022)

Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target
por: Reiss, Allison B., et al.
Publicado: (2023)

Dementia and Diet, Methodological and Statistical Issues: A Pilot Study
por: Stecker, Mark, et al.
Publicado: (2022)

Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer’s Disease, and Other Dementias
por: Ding, Helen, et al.
Publicado: (2022)

Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?
por: Yang, Ning, et al.
Publicado: (2015)

Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy
por: Reiss, Allison B., et al.
Publicado: (2019)

Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model
por: Kasselman, Lora J., et al.
Publicado: (2022)

Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk
por: Ahmed, Saba, et al.
Publicado: (2021)

Ongoing Use of SSRIs Does Not Alter Outcome in Hospitalized COVID-19 Patients: A Retrospective Analysis
por: Rauchman, Steven H., et al.
Publicado: (2021)

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
por: Taskinen, Marja-Riitta, et al.
Publicado: (2016)

Cardiovascular Disease Complicating COVID-19 in the Elderly
por: Dayaramani, Christopher, et al.
Publicado: (2021)

Therapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer’s Disease
por: Srivastava, Ankita, et al.
Publicado: (2023)

Fostering student and faculty scholarship in an accelerated three-year medical school
por: Kasselman, Lora J., et al.
Publicado: (2022)

miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
por: Zhou, Shan-shan, et al.
Publicado: (2018)

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
por: Williams, Tosha, et al.
Publicado: (2020)

Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease
por: Cuthbert, Gary A., et al.
Publicado: (2020)

Apolipoprotein B in cardiovascular risk assessment
por: Ahmad, Maud, et al.
Publicado: (2023)

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders
por: del Valle, Eva, et al.
Publicado: (2023)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021)

Cold Exposure Exacerbates the Development of Diabetic Polyneuropathy in the Rat
por: Kasselman, Lora J., et al.
Publicado: (2009)

Gut bacterial taxonomic abundances vary with cognition, personality, and mood in the Wisconsin Longitudinal Study
por: Renson, Audrey, et al.
Publicado: (2020)

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly
por: Haan, Mary N., et al.
Publicado: (2010)

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
por: Vecchio, Filomena Lo, et al.
Publicado: (2022)

Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs
por: Barberio, Matthew D., et al.
Publicado: (2019)

Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
por: Schmidt, Amand F., et al.
Publicado: (2023)

Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012)

Apolipoprotein: prospective biomarkers in digestive tract cancer
por: Zhang, Yibo, et al.
Publicado: (2020)

Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target
por: Sagris, Marios, et al.
Publicado: (2022)

Inflammation in Cardiovascular Disease: A Comprehensive Review of Biomarkers and Therapeutic Targets
por: Gupta, Lovish, et al.
Publicado: (2023)

Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease
por: Wang, Weitie, et al.
Publicado: (2019)

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020)

Identification of Apolipoprotein E as a Potential Diagnostic Biomarker of Nasopharyngeal Carcinoma
por: Xue, Ying, et al.
Publicado: (2020)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
por: Mahley, Robert W.
Publicado: (2016)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
por: Ceci, Flavio M., et al.
Publicado: (2021)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
por: Chen, Wei-Ling, et al.
Publicado: (2021)

Therapeutic Potential of EVs: Targeting Cardiovascular Diseases
por: Laura Francés, Javier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sv3tplrtobrphqmk63p7l2dd1b